Latest News and Press Releases
Want to stay updated on the latest news?
-
2025/26Interim financial results, H1 2025/261 October 2025 - 31 March 2026 Coloplast delivered Q2 organic growth of 6% and 6% EBIT growth1 in constant currencies. Strong quarter in Chronic Care and...
-
2025/26Delårsrapport, første halvår 2025/261. oktober 2025 - 31. marts 2026 Coloplast leverede i Q2 en organisk vækst på 6% og en EBIT-vækst1 på 6% i faste valutakurser. Stærkt kvartal i Chronic Care...
-
The contract is awarded for products that bring improvement to the healthcare industry. Coloplast, a global medical device company and market leader in intimate healthcare, has received an Innovative...
-
Announcement no. 04/2026Inside information Coloplast revises the financial guidance on organic growth and EBIT growth in constant currencies before special items for FY 2025/26, reflecting a slower...
-
Selskabsmeddelelse nr. 04/2026 Intern viden Coloplast reviderer de finansielle forventninger til organisk vækst og EBIT-vækst i faste valutakurser før særlige poster for regnskabsåret 2025/26,...
-
Tuesday, 12 May 2026 at 11:00 - 12:00 CESTIn connection with the publication of Coloplast’s interim financial results for H1 2025/26, to be released same day around 07:30 CEST, Coloplast will host a...
-
Please see enclosed pdf. Attachment 12032026_trading_in_shares_ALS ...
-
Se venligst vedlagte pdf. Vedhæftet fil 12032026_handel_med_aktier_ALS ...
-
Please see enclosed pdf. Attachment 11032026_trading_in_shares_JNA ...
-
Se venligst vedlagte pdf. Vedhæftet fil 11032026_handel_med_aktier_JNA ...